期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Atypical chemokine receptor CCRL2 is overexpressed in prostate cancer cells 被引量:1
1
作者 Niradiz Reyes Ines Benedetti +2 位作者 juan rebollo Oscar Correa Jan Geliebter 《The Journal of Biomedical Research》 CAS CSCD 2019年第1期17-23,共7页
Atypical chemokine receptors have recently emerged as important molecular players in health and diseases; they affect chemokine availability and function and impact a multitude of pathophysiological events, including ... Atypical chemokine receptors have recently emerged as important molecular players in health and diseases; they affect chemokine availability and function and impact a multitude of pathophysiological events, including the tumorigenesis process. This family of atypical receptors comprises five members: ACKR1/DARC, ACKR2/D6,ACKR3/CXCR7, ACKR4/CCRL1, and ACKR5/CCRL2. This work evaluated the differential expression of these receptors in prostate cancer using quantitative PCR. Further evaluation of CCRL2 at the protein level confirmed its overexpression in a metastatic cell line and in malignant prostatic tissues from patients. CCRL2, a presumed member of the atypical chemokine receptor family, plays a key role in lung dendritic cell trafficking to peripheral lymph nodes.Recent studies have reported the expression of CCRL2 in different human cancer cell lines and tissues. However, its function and expression in prostate cancer has not been previously addressed. 展开更多
关键词 CHEMOKINE RECEPTOR PROSTATIC NEOPLASMS CCRL2 RECEPTOR real-time POLYMERASE chain reaction tissue array analysis
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部